Table 3.
In situ hybridization showing mRNA levels in control and transgenic R6/2 mice
ISH probe | Striatum
|
Cortex
|
||
---|---|---|---|---|
Control | Transgenic | Control | Transgenic | |
mGluR1 | ||||
4 weeks | 245.5 ± 12.1 | 187.9 ± 9.1* | 100 ± 6.1 | 90.9 ± 6.1 |
8 weeks | 261.5 ± 30.7 | 126.9 ± 7.7* | 100 ± 11.5 | 80.8 ± 3.8 |
12 weeks | 278.4 ± 35.3 | 143.1 ± 9.8* | 100 ± 5.9 | 72.5 ± 5.8* |
mGluR2 | ||||
4 weeks | 28.8 ± 1.5 | 27.2 ± 1.5 | 100 ± 3.0 | 81.8 ± 7.6 |
8 weeks | 15.2 ± 1.5 | 6.6 ± 1.5 | 100 ± 7.7 | 56.4 ± 5.1† |
12 weeks | 28.8 ± 1.5 | 36.4 ± 1.5 | 100 ± 5.3 | 54.9 ± 3.5‡ |
mGluR3 | ||||
4 weeks | 77.2 ± 4.7 | 77.6 ± 5.6 | 100 ± 6.3 | 84.3 ± 5.5 |
8 weeks | 86.2 ± 6.2 | 66.7 ± 4.6 | 100 ± 7.7 | 76.9 ± 7.7 |
12 weeks | 59.6 ± 5.6 | 41.4 ± 2.5 | 100 ± 5.6 | 58.6 ± 2.5‡ |
mGluR5 | ||||
4 weeks | 211.3 ± 11.3 | 196.9 ± 6.2 | 100 ± 5.1 | 113.4 ± 3.1 |
12 weeks | 236.5 ± 22.4 | 197.9 ± 14.6 | 100 ± 8.3 | 114.6 ± 10.3 |
NMDA-R1 | ||||
4 weeks | 77.7 ± 3.6 | 67.4 ± 3.6 | 100 ± 5.2 | 93.4 ± 5.7 |
8 weeks | 76.6 ± 5.7 | 55.3 ± 4.5 | 100 ± 6.1 | 90.2 ± 8.6 |
12 weeks | 77.1 ± 8.7 | 80.8 ± 6.6 | 100 ± 8.9 | 96.9 ± 6.8 |
D1 dopamine | ||||
4 weeks | 100 ± 7.7 | 53.8 ± 2.8† | – | – |
8 weeks | 100 ± 8.7 | 60.5 ± 6.3* | – | – |
12 weeks | 100 ± 4.3 | 37.7 ± 1.7‡ | – | – |
D2 dopamine | ||||
4 weeks | 100 ± 3.1 | 82.3 ± 5.1 | – | – |
8 weeks | 100 ± 8.1 | 39.0 ± 4.2‡ | – | – |
β-actin | ||||
4 weeks | 94.2 ± 1.9 | 89.6 ± 1.9 | 100 ± 1.9 | 96.1 ± 1.9 |
12 weeks | 94.5 ± 7.4 | 86.8 ± 6.1 | 100 ± 4.3 | 101.5 ± 5.2 |
Numbers represent film optical density (OD) expressed as a percentage of signal in the cortex of control mice (mean ± SEM, n = 6–8 mice per group). For D1 and D2 dopamine receptor mRNA, numbers represent film OD expressed as a percentage of signal in striatum of control mice.
P < 0.01;
P < 0.001;
P < 0.0001.